White matter abnormalities in Parkinson's disease patients with glucocerebrosidase gene mutations

Movement Disorders

Volumn 28, Issue 6, 2013, Pages 772-778

  Agosta, Federica ^a   Kostic, Vladimir S ^b   Davidovic, Kristina ^a,b   Kresojević, Nikola ^b   Sarro, Lidia ^a   Svetel, Marina ^b   Stanković, Iva ^b   Comi, Giancarlo ^a   Klein, Christine ^c   Filippi, Massimo ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Diffusion tensor MRI; Glucocerebrosidase gene; MRI; Parkinson's disease; White matter pathology

Indexed keywords

GLUCOSYLCERAMIDASE;

ADULT; AGED; ARTICLE; CAPSULA INTERNA; CENTRAL NERVOUS SYSTEM DISEASE; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS CALLOSUM; DIFFUSION TENSOR IMAGING; EXTERNAL CAPSULE; FEMALE; FRACTIONAL ANISOTROPY; GENE MUTATION; HETEROZYGOTE; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; OLFACTORY TRACT; PARKINSON DISEASE; PRIORITY JOURNAL; VOXEL BASED MORPHOMETRY; WHITE MATTER ABNORMALITY;

AGED; AGED, 80 AND OVER; ANISOTROPY; BRAIN; CASE-CONTROL STUDIES; DIFFUSION TENSOR IMAGING; FEMALE; FUNCTIONAL LATERALITY; GLUCOSYLCERAMIDASE; HUMANS; MALE; MIDDLE AGED; MUTATION; NERVE FIBERS, MYELINATED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; STATISTICS, NONPARAMETRIC;

EID: 84879604928     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25397     Document Type: Article

References (31)

1. Sidransky E, Nalls MA, Aasly JO, et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med. 2009;361:1651-1661.
2. Neumann J, Bras J, Deas E, et al. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease. Brain. 2009;132:1783-1794.
3. Clark LN, Kartsaklis LA, Wolf Gilbert R, et al. Association of glucocerebrosidase mutations with dementia with Lewy bodies. Arch Neurol. 2009;66:578-583.
4. Goker-Alpan O, Stubblefield BK, Giasson BI, Sidransky E. Glucocerebrosidase is present in alpha-synuclein inclusions in Lewy body disorders. Acta Neuropathol. 2010;120:641-649.
5. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55:181-184.
6. Kumar KR, Ramirez A, Gobel A, et al. Glucocerebrosidase mutations in a Serbian Parkinson's disease population. Eur J Neurol. 2013;20:402-405.
7. Emre M, Aarsland D, Brown R, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord. 2007;22:1689-1707; quiz 1837.
8. Litvan I, Goldman JG, Troster AI, et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord. 2012;27:349-356.
9. Studholme C, Hill DL, Hawkes DJ. Automated three-dimensional registration of magnetic resonance and positron emission tomography brain images by multiresolution optimization of voxel similarity measures. Med Phys. 1997;24:25-35.
10. Pierpaoli C, Jezzard P, Basser PJ, Barnett A, Di Chiro G. Diffusion tensor MR imaging of the human brain. Radiology. 1996;201:637-648.
11. Smith SM, Jenkinson M, Johansen-Berg H, et al. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage. 2006;31:1487-1505.
12. Ashburner J. A fast diffeomorphic image registration algorithm. Neuroimage. 2007;38:95-113.
13. Ashburner J, Friston KJ. Unified segmentation. Neuroimage. 2005;26:839-851.
14. McLaren DG, Kosmatka KJ, Kastman EK, Bendlin BB, Johnson SC. Rhesus macaque brain morphometry: a methodological comparison of voxel-wise approaches. Methods. 2009;50:157-165.
15. Nichols TE, Holmes AP. Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum Brain Mapp. 2002;15:1-25.
16. Smith SM, Nichols TE. Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage. 2009;44:83-98.
17. Agosta F, Canu E, Stojkovic T, et al. The topography of brain damage at different stages of Parkinson's disease. Hum Brain Mapp. 2012 [Epub ahead of print].
18. Hattori T, Orimo S, Aoki S, et al. Cognitive status correlates with white matter alteration in Parkinson's disease. Hum Brain Mapp. 2012;33:727-739.
19. Karagulle Kendi AT, Lehericy S, Luciana M, Ugurbil K, Tuite P. Altered diffusion in the frontal lobe in Parkinson disease. AJNR Am J Neuroradiol. 2008;29:501-505.
20. Rae CL, Correia MM, Altena E, Hughes LE, Barker RA, Rowe JB. White matter pathology in Parkinson's disease: the effect of imaging protocol differences and relevance to executive function. Neuroimage. 2012;62:1675-1684.
21. Zhan W, Kang GA, Glass GA, et al. Regional alterations of brain microstructure in Parkinson's disease using diffusion tensor imaging. Mov Disord. 2012;27:90-97.
22. Aarsland D, Zaccai J, Brayne C. A systematic review of prevalence studies of dementia in Parkinson's disease. Mov Disord. 2005;20:1255-1263.
23. Matsui H, Nishinaka K, Oda M, et al. Wisconsin Card Sorting Test in Parkinson's disease: diffusion tensor imaging. Acta Neurol Scand. 2007;116:108-112.
24. Kostic VS, Agosta F, Petrovic I, et al. Regional patterns of brain tissue loss associated with depression in Parkinson disease. Neurology. 2010;75:857-863.
25. Braak H, Sandmann-Keil D, Gai W, Braak E. Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by alpha-synuclein immunocytochemistry. Neurosci Lett. 1999;265:67-69.
26. Katsuse O, Iseki E, Marui W, Kosaka K. Developmental stages of cortical Lewy bodies and their relation to axonal transport blockage in brains of patients with dementia with Lewy bodies. J Neurol Sci. 2003;211:29-35.
27. Bohnen NI, Albin RL. White matter lesions in Parkinson disease. Nat Rev Neurol. 2011;7:229-236.
28. Whitwell JL, Josephs KA. Voxel-based morphometry and its application to movement disorders. Parkinsonism Relat Disord. 2007;13(Suppl 3):S406-S416.
29. Song SK, Lee JE, Park HJ, Sohn YH, Lee JD, Lee PH. The pattern of cortical atrophy in patients with Parkinson's disease according to cognitive status. Mov Disord. 2011;26:289-296.
30. Pereira JB, Ibarretxe-Bilbao N, Marti MJ, et al. Assessment of cortical degeneration in patients with Parkinson's disease by voxel-based morphometry, cortical folding, and cortical thickness. Hum Brain Mapp. 2011;33:2521-2534.
31. Im K, Lee JM, Seo SW, Hyung Kim S, Kim SI, Na DL. Sulcal morphology changes and their relationship with cortical thickness and gyral white matter volume in mild cognitive impairment and Alzheimer's disease. Neuroimage. 2008;43:103-113.